EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY-NC-ND 4.0

Correction to: “Diazoxide Choline Extended-Release (DCCR) Use in Prader–Willi Syndrome: Patient Selection, Dosing, and Management”

Journal of the Endocrine Society · 03.06.2026 · 10 (7)

DOI: 10.1210/jendso/bvag144 ↗

Kurz gefasst

Korrektur in der Zeitschrift Journal of the Endocrine Society, online erschienen am 01.07.2026. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

[This corrects the article DOI: 10.1210/jendso/bvag099.].

Zitieren

APA

(2026). Correction to: “Diazoxide Choline Extended-Release (DCCR) Use in Prader–Willi Syndrome: Patient Selection, Dosing, and Management”. Journal of the Endocrine Society, 10(7). https://doi.org/10.1210/jendso/bvag144

Vancouver

Correction to: “Diazoxide Choline Extended-Release (DCCR) Use in Prader–Willi Syndrome: Patient Selection, Dosing, and Management”. Journal of the Endocrine Society. 2026;10(7). doi:10.1210/jendso/bvag144

BibTeX
@article{euvimed2026,
  title = {Correction to: “Diazoxide Choline Extended-Release (DCCR) Use in Prader–Willi Syndrome: Patient Selection, Dosing, and Management”},
  journal = {Journal of the Endocrine Society},
  year = {2026},
  volume = {10},
  number = {7},
  doi = {10.1210/jendso/bvag144}
}
Kostenlos starten →